Collegium Pharmaceutical Inc (COLL) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Collegium Pharmaceutical Inc (COLL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($78.44 Million) in capital expenditures ($188.00K). See Collegium Pharmaceutical Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$78.44 Million
USD
Capital Expenditures
$188.00K
USD
Data as of
Sep 2025
Most recent filing
Collegium Pharmaceutical Inc Capital Reinvestment Ratio (2018–2024)
This chart tracks Collegium Pharmaceutical Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year Capital Reinvestment Ratio for Collegium Pharmaceutical Inc from 2018 to 2024. For live market cap and broader valuation context, see COLL company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $204.98 Million | $1.65 Million | ▲ +380.3% |
| 2023 | 0.00x | $274.75 Million | $461.00K | ▼ -87.1% |
| 2022 | 0.01x | $124.23 Million | $1.62 Million | ▼ -30.4% |
| 2021 | 0.02x | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 3.98x | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.23x | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.14x | $169.39 Million | $24.35 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow